Free Trial
NASDAQ:OM

Outset Medical Q2 2025 Earnings Report

Outset Medical logo
$14.10 -0.06 (-0.42%)
Closing price 08/5/2025 04:00 PM Eastern
Extended Trading
$13.37 -0.73 (-5.18%)
As of 08/5/2025 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Upcoming Event
Earnings Conference Call
Outset Medical Q2 2025
00:00 / 00:00
Live Transcript
Follow Audio

Outset Medical EPS Results

Actual EPS
N/A
Consensus EPS
-$1.76
Beat/Miss
N/A
One Year Ago EPS
N/A

Outset Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
$29.40 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Outset Medical Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, August 6, 2025
Conference Call Time
5:00PM ET

Conference Call Resources

Outset Medical Earnings Headlines

Uncovering Potential: Outset Medical's Earnings Preview
Outset Medical (OM) to Release Earnings on Wednesday
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Outset Medical Names First Chief Nursing Officer
See More Outset Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Outset Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Outset Medical and other key companies, straight to your email.

About Outset Medical

Outset Medical (NASDAQ:OM), a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

View Outset Medical Profile

More Earnings Resources from MarketBeat